Pharmafile Logo
Pharmafocus logo
Advanced Search
almac_building

Almac Group announces £27 million global expansion

November 11, 2016
Medical Communications, Sales and Marketing Almac Group, investment

Almac Group, a global contract pharmaceutical development and manufacturing organisation, has announced that it will spend £27 million in a …

News
bionical

Bionical adds Emas Pharma in strategic acquisition

November 11, 2016
Medical Communications, Sales and Marketing Bionical, Emas pharma, acquistion

Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, has announced the acquisition of Emas Pharma. …

News
alexion_solirispackaging

Alexion begins internal probe into sales practices

November 11, 2016
Medical Communications Alexion, sales practices

Alexion Pharmaceuticals released a statement that it was to begin conducting an internal investigation into sales practices for Soliris (eculizumb) …

News
california

Proposition 61 defeated to allay changes on drug pricing

November 11, 2016
Medical Communications Bernie Sanders, Drug pricing, Proposition 61, california

Another major piece of voting news emerged on 9 November, with Proposition 61 voted down by Californian residents, with the …

News
ex-roche_guy

Former Roche CEO joins Arix Bioscience as senior independent director

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. …

Appointment
nhs_trees

Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court

A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …

News
shutterstock_157775444

Social media and mobile apps: Bringing people and clinical trials together

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In part one, we looked at the difficulty in recruiting and retaining patients for clinical trials, and how increased communication …

Feature

Pfizer’s breast cancer drug gets EU approval

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Novartis, Pfizer, ibrance

Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …

News
novavax

Novavax cuts works force by a third in struggle to restructure

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost cutting, Jobs, Novavax, losses

Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …

News
apps_mobile

Chinese FDA releases “drug scanner” app

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Food and Drug Administration, app

The China Food and Drug Administration (CFDA) has released a new app earlier this week which enables users to download …

News
janssen_stairs

Collaboration on new therapeutic vaccine for HIV shows promise

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Janssen, Johnson & Johnson

Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …

News

Pfizer to shut two out of three manufacturing plants in UK

November 9, 2016
Manufacturing and Production, Research and Development Pfizer, UK, manufacturing, production, sites

Pfizer has announced that it will close two of the three manufacturing plants it still holds in the UK. The …

News
amgen_hq

NICE turns down Amgen’s multiple myeloma drug

November 9, 2016
Research and Development, Sales and Marketing Amgen, Kyprolis, NICE

Amgen has seen its drug Kyprolis (carfilzomib) rejected by NICE for its routine use in the treatment of multiple myeloma …

News
valeant

Valeant’s tough year gets worse with Q3 loss of $1.22 billion

November 9, 2016
Research and Development Q3, Valeant, loss

It’s easy to say that Valeant hasn’t had a great year so far. Unfortunately for those concerned, the outlook for …

News
code

BenevolentAI announces licensing agreement with Janssen

November 8, 2016
Research and Development Janssen, Johnson & Johnson, artificial intelligence

BenevolentAI, a British artificial intelligence company, announced a licensing agreement to develop a select number of drug candidates with Janssen, …

News
irina_antonijevic_image

Irina Antonijevic appointed as chief medical officer at vasopharm

November 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

vasopharma, a privately held biopharmaceutical company, announced on 8 November that it had appointed Irina Antonijevic as their chief medical …

Appointment
cvnef_xxeaeoa4i

Free Pharmacovigilance Webinar: Only one day left to register!

November 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmacovigilance

There is only one more day to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …

News
digital_pharma

FDA clears digital sensor for GSK inhaler

November 8, 2016
Manufacturing and Production, Sales and Marketing FDA, GSK, GlaxoSmithKline, Propeller Health, ellipta

The FDA has given 510(k) clearance to a smart inhaler sensor developed by Propeller Health for use with GlaxoSmithKline’s Ellipta …

News
abbott_humira

Coherus knocked back by AbbVie’s Humira patent protection

November 8, 2016
Manufacturing and Production, Sales and Marketing AbbVie, Coherus, Humira

Coherus Biosciences, a developer of biosimilars, has suffered a blow in their petition for Inter Partes Review (IPR) of one …

News
sicorbio

Teva antihypertensive generic duo gets FDA thumbs up

November 7, 2016
Manufacturing and Production, Sales and Marketing Azor, FDA, Teva, Tribenzor

Teva has received the approval from the US Food and Drug Administration (FDA) for its generic hypertension treatments Tribenzor (olmesartan …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026